Aesthetic pharmaceutical company Croma Pharma has unveiled Exprecell, a new medical device designed for the preparation of autologous platelet-rich plasma (PRP).
The MDR-approved, all-in-one system is used to prepare both autologous PRP and fluid platelet-rich fibrin (Fluid-PRF), enabling the efficient production of autologous blood concentrates without the use of anticoagulants.
According to the company, this process results in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes while remaining liquid for a defined period.
Croma Pharma adds that Exprecell’s high-capacity single-syringe system allows for blood aspiration and PRP preparation from whole blood using a single spin, with a spin time of just five minutes.
Vikki Baker, commercial director at Croma Pharma UK for the Netherlands and Nordics, commented, “We are delighted to announce the addition of Exprecell to our portfolio, offering a next-generation solution for fast, anticoagulant-free preparation of PRP. This launch represents Croma’s continued mission to provide healthcare professionals with state-of-the-art tools that support clinical performance, efficiency and quality of care.”
Aesthetic practitioner Dr Munir Somji, global key opinion leader for Croma UK, added, “I am proud to be one of the first practitioners to offer Exprecell in the UK. With the growing patient demand for regenerative treatments, it’s exciting to provide an MDR-approved solution for autologous PRP and FPF (Fluid-PRF).”